The NMDA receptor antagonist ketamine impairs and delays context-dependent decision making in the parietal cortex
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2399-3642
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The NMDA receptor antagonist ketamine impairs and delays context-dependent decision making in the parietal cortex ; volume:5 ; number:1 ; day:20 ; month:7 ; year:2022 ; pages:1-12 ; date:12.2022
Communications biology ; 5, Heft 1 (20.7.2022), 1-12, 12.2022
- Creator
-
Suda, Yuki
Uka, Takanori
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s42003-022-03626-z
- URN
-
urn:nbn:de:101:1-2022091922541276207954
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Suda, Yuki
- Uka, Takanori
- SpringerLink (Online service)
Other Objects (12)
Neural population dynamics and frontal-parietal circuit for context-dependent sensorimotor computations
The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
GDF-5 can act as a context-dependent BMP-2 antagonist
Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation
The AMPA antagonist GYKI 52466 reverses the anticataleptic effects of the competitive NMDA antagonist CGP 37849
The NMDA antagonist dizocilpine (MK-801) reverses haloperidol-induced movement initiation deficits
NMDA 2A receptors in parvalbumin cells mediate sex-specific rapid ketamine response on cortical activity
NMDA receptor antagonist high-frequency oscillations are transmitted via bottom-up feedforward processing
Der NMDA-Antagonist Ketamin zur Behandlung der Aurasymptomatik bei Patienten mit familiärer hemiplegischer Migräne
Development of parietal bone surrogates for parietal graft lift training
Der nicht-kompetitive NMDA-Rezeptor-Antagonist Memantin in der Therapie intrazerebraler Blutungen : eine tierexperimentelle Untersuchung
Der NMDA Antagonist Neramexane im transgenen Tiermodell mit Amyotropher Lateralsklerose: Effekte auf Funktion und Überleben
Neural population dynamics and frontal-parietal circuit for context-dependent sensorimotor computations
The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
GDF-5 can act as a context-dependent BMP-2 antagonist
Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation
The AMPA antagonist GYKI 52466 reverses the anticataleptic effects of the competitive NMDA antagonist CGP 37849
The NMDA antagonist dizocilpine (MK-801) reverses haloperidol-induced movement initiation deficits
NMDA 2A receptors in parvalbumin cells mediate sex-specific rapid ketamine response on cortical activity
NMDA receptor antagonist high-frequency oscillations are transmitted via bottom-up feedforward processing
Der NMDA-Antagonist Ketamin zur Behandlung der Aurasymptomatik bei Patienten mit familiärer hemiplegischer Migräne
Development of parietal bone surrogates for parietal graft lift training
Der nicht-kompetitive NMDA-Rezeptor-Antagonist Memantin in der Therapie intrazerebraler Blutungen : eine tierexperimentelle Untersuchung
Der NMDA Antagonist Neramexane im transgenen Tiermodell mit Amyotropher Lateralsklerose: Effekte auf Funktion und Überleben
Neural population dynamics and frontal-parietal circuit for context-dependent sensorimotor computations
The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
GDF-5 can act as a context-dependent BMP-2 antagonist
Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation
The AMPA antagonist GYKI 52466 reverses the anticataleptic effects of the competitive NMDA antagonist CGP 37849
The NMDA antagonist dizocilpine (MK-801) reverses haloperidol-induced movement initiation deficits
NMDA 2A receptors in parvalbumin cells mediate sex-specific rapid ketamine response on cortical activity
NMDA receptor antagonist high-frequency oscillations are transmitted via bottom-up feedforward processing
Der NMDA-Antagonist Ketamin zur Behandlung der Aurasymptomatik bei Patienten mit familiärer hemiplegischer Migräne
Development of parietal bone surrogates for parietal graft lift training
Der nicht-kompetitive NMDA-Rezeptor-Antagonist Memantin in der Therapie intrazerebraler Blutungen : eine tierexperimentelle Untersuchung